Actionable insights straight to your inbox

logo_equities.svg

Trademark Application for “ALPROLIX” Filed by Biogen Idec MA

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “ALPROLIX” by Brenda Campbell, Trademark Paralegal, representing Biogen Idec MA. This application was made available to the public on June 27, 2014 (see also Pharmaceutical Companies).
The international trademark goods and services class code for this trademark application is 044.
The serial number for this application is 86310233.
As submitted by the applicant, this trademark application relates to the following goods and services: Providing medical information in the field of hemophilia.
The owner/registrar information for this application is: Brenda Campbell, Trademark Paralegal, Biogen Idec MA, 225 Binney St, Cambridge, MA 02142-1031.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, Biogen Idec MA, Biotechnology Companies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Many people think of position size in terms of how many shares they own of a particular stock. But it’s much smarter to think of it in terms of what percentage of your total capital is in a particular stock.